XML 122 R103.htm IDEA: XBRL DOCUMENT v3.7.0.1
Guarantor Financial Information , Condensed Consolidating Statement of Cash Flows (Details) - USD ($)
$ in Millions
 12 Months Ended
Apr. 28, 2017
Apr. 29, 2016
Apr. 24, 2015
Operating Activities:      
Net cash provided by operating activities $ 6,880 $ 5,218 $ 4,902
Investing Activities:      
Acquisitions, net of cash acquired (1,324) (1,213) (14,884)
Additions to property, plant, and equipment (1,254) (1,046) (571)
Purchases of investments (4,371) (5,406) (7,582)
Sales and maturities of investments 5,356 9,924 5,890
Net (increase) decrease in intercompany loans receivable 0 0 0
Sale of subsidiaries   0  
Capital contributions paid 0 0 0
Other investing activities, net 22 (14) 89
Net cash (used in) provided by investing activities (1,571) 2,245 (17,058)
Financing Activities:      
Acquisition-related contingent consideration (69) (22) (85)
Change in current debt obligations, net 906 7 (1)
Repayment of short-term borrowings (maturities greater than 90 days) (2) (139) (150)
Proceeds from short-term borrowings (maturities greater than 90 days) 12 139 150
Issuance of long-term debt 2,140 0 19,942
Payments on long-term debt (863) (5,132) (1,268)
Dividends to shareholders (2,376) (2,139) (1,337)
Issuance of ordinary shares 428 491 649
Repurchase of ordinary shares (3,544) (2,830) (1,920)
Net intercompany loan borrowings (repayments) 0 0 0
Intercompany dividend paid 0 0 0
Capital contributions received 0 0 0
Other financing activities 85 82 (31)
Net cash (used in) provided by financing activities (3,283) (9,543) 15,949
Effect of exchange rate changes on cash and cash equivalents 65 113 (353)
Net change in cash and cash equivalents 2,091 (1,967) 3,440
Cash and cash equivalents at beginning of period 2,876 4,843 1,403
Cash and cash equivalents at end of period 4,967 2,876 4,843
Consolidating Adjustments | Medtronic Notes      
Operating Activities:      
Net cash provided by operating activities (887) (812) (413)
Investing Activities:      
Acquisitions, net of cash acquired 0 0 0
Additions to property, plant, and equipment 0 0 0
Purchases of investments 162 0 0
Sales and maturities of investments (162) 0 0
Net (increase) decrease in intercompany loans receivable 13,813 10,492 16,943
Capital contributions paid 248 9,870  
Other investing activities, net 0 0 0
Net cash (used in) provided by investing activities 14,061 20,362 16,943
Financing Activities:      
Acquisition-related contingent consideration 0 0 0
Change in current debt obligations, net 0 0 0
Repayment of short-term borrowings (maturities greater than 90 days) 0 0 0
Proceeds from short-term borrowings (maturities greater than 90 days) 0 0 0
Issuance of long-term debt 0   0
Payments on long-term debt 0 0 0
Dividends to shareholders 0 0 0
Issuance of ordinary shares 0 0 0
Repurchase of ordinary shares 0 0 0
Net intercompany loan borrowings (repayments) (13,813) (10,492) (16,943)
Intercompany dividend paid 887 812 413
Capital contributions received (248) (9,870)  
Other financing activities 0 0 0
Net cash (used in) provided by financing activities (13,174) (19,550) (16,530)
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of period 0 0 0
Cash and cash equivalents at end of period 0 0 0
Consolidating Adjustments | CIFSA Senior Notes      
Operating Activities:      
Net cash provided by operating activities (1,997) (4,005) (1,100)
Investing Activities:      
Acquisitions, net of cash acquired 0 53 0
Additions to property, plant, and equipment 0 0 0
Purchases of investments 0 0 0
Sales and maturities of investments 0 0 0
Net (increase) decrease in intercompany loans receivable (3,320) 11,659 10,656
Sale of subsidiaries   (53)  
Capital contributions paid 537 5,679 937
Other investing activities, net 0 0 0
Net cash (used in) provided by investing activities (2,783) 17,338 11,593
Financing Activities:      
Acquisition-related contingent consideration 0 0 0
Change in current debt obligations, net 0 0 0
Repayment of short-term borrowings (maturities greater than 90 days) 0 0 0
Proceeds from short-term borrowings (maturities greater than 90 days) 0 0 0
Issuance of long-term debt 0   0
Payments on long-term debt 0 0 0
Dividends to shareholders 0 0 0
Issuance of ordinary shares 0 0 0
Repurchase of ordinary shares 0 0 0
Net intercompany loan borrowings (repayments) 3,320 (11,659) (10,656)
Intercompany dividend paid 1,997 4,005 1,100
Capital contributions received (537) (5,679) (937)
Other financing activities 0 0 0
Net cash (used in) provided by financing activities 4,780 (13,333) (10,493)
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of period 0 0 0
Cash and cash equivalents at end of period 0 0 0
Medtronic plc | Medtronic Notes      
Operating Activities:      
Net cash provided by operating activities 842 297 26
Investing Activities:      
Acquisitions, net of cash acquired 0 0 (9,700)
Additions to property, plant, and equipment 0 0 0
Purchases of investments 0 0 0
Sales and maturities of investments 0 0 0
Net (increase) decrease in intercompany loans receivable 0 0 0
Capital contributions paid 0 0  
Other investing activities, net 0 0 0
Net cash (used in) provided by investing activities 0 0 (9,700)
Financing Activities:      
Acquisition-related contingent consideration 0 0 0
Change in current debt obligations, net 0 0 0
Repayment of short-term borrowings (maturities greater than 90 days) 0 0 0
Proceeds from short-term borrowings (maturities greater than 90 days) 0 0 0
Issuance of long-term debt 0   0
Payments on long-term debt 0 0 0
Dividends to shareholders (2,376) (2,139) (435)
Issuance of ordinary shares 428 491 172
Repurchase of ordinary shares (3,544) (2,830) (300)
Net intercompany loan borrowings (repayments) 4,650 3,918 10,500
Intercompany dividend paid 0 0 0
Capital contributions received 0 0  
Other financing activities 0 0 0
Net cash (used in) provided by financing activities (842) (560) 9,937
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents 0 (263) 263
Cash and cash equivalents at beginning of period 0 263 0
Cash and cash equivalents at end of period 0 0 263
Medtronic plc | CIFSA Senior Notes      
Operating Activities:      
Net cash provided by operating activities 842 297 26
Investing Activities:      
Acquisitions, net of cash acquired 0 0 (9,700)
Additions to property, plant, and equipment 0 0 0
Purchases of investments 0 0 0
Sales and maturities of investments 0 0 0
Net (increase) decrease in intercompany loans receivable 0 0 0
Sale of subsidiaries   0  
Capital contributions paid 0 0 0
Other investing activities, net 0 0 0
Net cash (used in) provided by investing activities 0 0 (9,700)
Financing Activities:      
Acquisition-related contingent consideration 0 0 0
Change in current debt obligations, net 0 0 0
Repayment of short-term borrowings (maturities greater than 90 days) 0 0 0
Proceeds from short-term borrowings (maturities greater than 90 days) 0 0 0
Issuance of long-term debt 0   0
Payments on long-term debt 0 0 0
Dividends to shareholders (2,376) (2,139) (435)
Issuance of ordinary shares 428 491 172
Repurchase of ordinary shares (3,544) (2,830) (300)
Net intercompany loan borrowings (repayments) 4,650 3,918 10,500
Intercompany dividend paid 0 0 0
Capital contributions received 0 0 0
Other financing activities 0 0 0
Net cash (used in) provided by financing activities (842) (560) 9,937
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents 0 (263) 263
Cash and cash equivalents at beginning of period 0 263 0
Cash and cash equivalents at end of period 0 0 263
Subsidiary Issuer | Medtronic Notes      
Operating Activities:      
Net cash provided by operating activities 1,902 402 1,479
Investing Activities:      
Acquisitions, net of cash acquired (940) (526) (65)
Additions to property, plant, and equipment (369) (334) (187)
Purchases of investments 0 0 0
Sales and maturities of investments 210 0 0
Net (increase) decrease in intercompany loans receivable (3,278) (2,368) (16,996)
Capital contributions paid (248) (11)  
Other investing activities, net 0 0 0
Net cash (used in) provided by investing activities (4,625) (3,239) (17,248)
Financing Activities:      
Acquisition-related contingent consideration 0 0 0
Change in current debt obligations, net 0 0 0
Repayment of short-term borrowings (maturities greater than 90 days) 0 0 (150)
Proceeds from short-term borrowings (maturities greater than 90 days) 0 0 150
Issuance of long-term debt 150   19,942
Payments on long-term debt (500) (2,988) (1,268)
Dividends to shareholders 0 0 (902)
Issuance of ordinary shares 0 0 477
Repurchase of ordinary shares 0 0 (1,620)
Net intercompany loan borrowings (repayments) 3,023 (91) (53)
Intercompany dividend paid 0 0 0
Capital contributions received 0 4,900  
Other financing activities 40 0 0
Net cash (used in) provided by financing activities 2,713 1,821 16,576
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents (10) (1,016) 807
Cash and cash equivalents at beginning of period 55 1,071 264
Cash and cash equivalents at end of period 45 55 1,071
Subsidiary Issuer | CIFSA Senior Notes      
Operating Activities:      
Net cash provided by operating activities 1,904 4,208 1,238
Investing Activities:      
Acquisitions, net of cash acquired 0 0 440
Additions to property, plant, and equipment 0 0 0
Purchases of investments 0 0 0
Sales and maturities of investments 0 0 0
Net (increase) decrease in intercompany loans receivable 5,275 (8,193) (59)
Sale of subsidiaries   0  
Capital contributions paid (537) (720) (937)
Other investing activities, net 0 0 0
Net cash (used in) provided by investing activities 4,738 (8,913) (556)
Financing Activities:      
Acquisition-related contingent consideration 0 0 0
Change in current debt obligations, net 0 0 0
Repayment of short-term borrowings (maturities greater than 90 days) 0 0 0
Proceeds from short-term borrowings (maturities greater than 90 days) 0 0 0
Issuance of long-term debt 0   0
Payments on long-term debt 0 (2,121) (51)
Dividends to shareholders 0 0 0
Issuance of ordinary shares 0 0 0
Repurchase of ordinary shares 0 0 0
Net intercompany loan borrowings (repayments) (6,817) 6,306 97
Intercompany dividend paid 0 0 0
Capital contributions received 0 0 0
Other financing activities 0 0 0
Net cash (used in) provided by financing activities (6,817) 4,185 46
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents (175) (520) 728
Cash and cash equivalents at beginning of period 208 728 0
Cash and cash equivalents at end of period 33 208 728
Subsidiary Guarantors | Medtronic Notes      
Operating Activities:      
Net cash provided by operating activities 302 696 170
Investing Activities:      
Acquisitions, net of cash acquired 0 0 0
Additions to property, plant, and equipment 0 0 0
Purchases of investments 0 0 0
Sales and maturities of investments 0 0 0
Net (increase) decrease in intercompany loans receivable (5,911) (203) 0
Capital contributions paid 0 (4,959)  
Other investing activities, net 0 0 0
Net cash (used in) provided by investing activities (5,911) (5,162) 0
Financing Activities:      
Acquisition-related contingent consideration 0 0 0
Change in current debt obligations, net 901 0 0
Repayment of short-term borrowings (maturities greater than 90 days) 0 (139) 0
Proceeds from short-term borrowings (maturities greater than 90 days) 0 139 0
Issuance of long-term debt 1,850   0
Payments on long-term debt 0 0 0
Dividends to shareholders 0 0 0
Issuance of ordinary shares 0 0 0
Repurchase of ordinary shares 0 0 0
Net intercompany loan borrowings (repayments) 2,863 4,296 0
Intercompany dividend paid 0 0 0
Capital contributions received 0 0  
Other financing activities 0 0 0
Net cash (used in) provided by financing activities 5,614 4,296 0
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents 5 (170) 170
Cash and cash equivalents at beginning of period 0 170 0
Cash and cash equivalents at end of period 5 0 170
Subsidiary Guarantors | CIFSA Senior Notes      
Operating Activities:      
Net cash provided by operating activities 302 604 142
Investing Activities:      
Acquisitions, net of cash acquired 0 0 0
Additions to property, plant, and equipment 0 0 (1)
Purchases of investments 0 0 0
Sales and maturities of investments 0 0 0
Net (increase) decrease in intercompany loans receivable (5,911) (164) 29
Sale of subsidiaries   53  
Capital contributions paid 0 (4,959) 0
Other investing activities, net 0 0 0
Net cash (used in) provided by investing activities (5,911) (5,070) 28
Financing Activities:      
Acquisition-related contingent consideration 0 0 0
Change in current debt obligations, net 901 0 0
Repayment of short-term borrowings (maturities greater than 90 days) 0 (139) (150)
Proceeds from short-term borrowings (maturities greater than 90 days) 0 139 150
Issuance of long-term debt 1,850   0
Payments on long-term debt 0 0 0
Dividends to shareholders 0 0 0
Issuance of ordinary shares 0 0 0
Repurchase of ordinary shares 0 0 0
Net intercompany loan borrowings (repayments) 2,863 4,296 0
Intercompany dividend paid 0 0 0
Capital contributions received 0 0 0
Other financing activities 0 0 0
Net cash (used in) provided by financing activities 5,614 4,296 0
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents 5 (170) 170
Cash and cash equivalents at beginning of period 0 170 0
Cash and cash equivalents at end of period 5 0 170
Subsidiary Non-guarantors | Medtronic Notes      
Operating Activities:      
Net cash provided by operating activities 4,721 4,635 3,640
Investing Activities:      
Acquisitions, net of cash acquired (384) (687) (5,119)
Additions to property, plant, and equipment (885) (712) (384)
Purchases of investments (4,533) (5,406) (7,582)
Sales and maturities of investments 5,308 9,924 5,890
Net (increase) decrease in intercompany loans receivable (4,624) (7,921) 53
Capital contributions paid 0 (4,900)  
Other investing activities, net 22 (14) 89
Net cash (used in) provided by investing activities (5,096) (9,716) (7,053)
Financing Activities:      
Acquisition-related contingent consideration (69) (22) (85)
Change in current debt obligations, net 5 7 (1)
Repayment of short-term borrowings (maturities greater than 90 days) (2) 0 0
Proceeds from short-term borrowings (maturities greater than 90 days) 12 0 0
Issuance of long-term debt 140   0
Payments on long-term debt (363) (2,144) 0
Dividends to shareholders 0 0 0
Issuance of ordinary shares 0 0 0
Repurchase of ordinary shares 0 0 0
Net intercompany loan borrowings (repayments) 3,277 2,369 6,496
Intercompany dividend paid (887) (812) (413)
Capital contributions received 248 4,970  
Other financing activities 45 82 (31)
Net cash (used in) provided by financing activities 2,406 4,450 5,966
Effect of exchange rate changes on cash and cash equivalents 65 113 (353)
Net change in cash and cash equivalents 2,096 (518) 2,200
Cash and cash equivalents at beginning of period 2,821 3,339 1,139
Cash and cash equivalents at end of period 4,917 2,821 3,339
Subsidiary Non-guarantors | CIFSA Senior Notes      
Operating Activities:      
Net cash provided by operating activities 5,829 4,114 4,596
Investing Activities:      
Acquisitions, net of cash acquired (1,324) (1,266) (5,624)
Additions to property, plant, and equipment (1,254) (1,046) (570)
Purchases of investments (4,371) (5,406) (7,582)
Sales and maturities of investments 5,356 9,924 5,890
Net (increase) decrease in intercompany loans receivable 3,956 (3,302) (10,626)
Sale of subsidiaries   0  
Capital contributions paid 0 0 0
Other investing activities, net 22 (14) 89
Net cash (used in) provided by investing activities 2,385 (1,110) (18,423)
Financing Activities:      
Acquisition-related contingent consideration (69) (22) (85)
Change in current debt obligations, net 5 7 (1)
Repayment of short-term borrowings (maturities greater than 90 days) (2) 0 0
Proceeds from short-term borrowings (maturities greater than 90 days) 12 0 0
Issuance of long-term debt 290   19,942
Payments on long-term debt (863) (3,011) (1,217)
Dividends to shareholders 0 0 (902)
Issuance of ordinary shares 0 0 477
Repurchase of ordinary shares 0 0 (1,620)
Net intercompany loan borrowings (repayments) (4,016) (2,861) 59
Intercompany dividend paid (1,997) (4,005) (1,100)
Capital contributions received 537 5,679 937
Other financing activities 85 82 (31)
Net cash (used in) provided by financing activities (6,018) (4,131) 16,459
Effect of exchange rate changes on cash and cash equivalents 65 113 (353)
Net change in cash and cash equivalents 2,261 (1,014) 2,279
Cash and cash equivalents at beginning of period 2,668 3,682 1,403
Cash and cash equivalents at end of period $ 4,929 $ 2,668 $ 3,682